XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2
EQUITY-BASED COMPENSATION (Tables)
 6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of restricted stock awards
The following table summarizes time-based restricted stock award activity under our Equity Plan for the six months ended June 30, 2022:
 
 Number
 of Shares		Weighted Average
Grant Date 
Fair Value		Aggregate
Current Value
  (per share)(in thousands)
Non-vested at December 31, 2021605,470 $9.98 $5,909 
Granted316,643 9.83  
Vested(259,044)(10.05) 
Forfeited(3,173)(10.29) 
Non-vested at June 30, 2022659,896 $9.85 $4,797 
The following table summarizes performance-based restricted stock activity under the Equity Plan for the six months ended June 30, 2022: 
 Number 
of Shares		Weighted Average
Grant Date 
Fair Value (1)		Aggregate
Current Value
  (per share)(in thousands)
Non-vested at December 31, 20211,002,866 $11.92 $9,788 
Granted306,435 9.83  
Vested(302,327)(12.81) 
Non-vested at June 30, 20221,006,974 $11.76 $7,321 

(1) The amounts included in this column represent the expected future value of the performance-based restricted stock awards calculated using the Monte Carlo simulation valuation model.
Schedule of equity-based compensation expense
Equity-based compensation expense included in Corporate general and administrative expenses in the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2022 and 2021 was as follows (in thousands):
 
For the Three Months Ended
June 30,		 For the Six Months Ended
June 30,
2022202120222021
Time-based restricted stock$651 $843 $1,645 $1,508 
Performance-based restricted stock720 974 3,393 1,878 
Director stock770 583 802 583 
$2,141 $2,400 $5,840 $3,969 
Schedule of unrecognized equity-based compensation expense for all non-vested awards
Unrecognized equity-based compensation expense for all non-vested awards pursuant to our Equity Plan was $10.9 million at June 30, 2022 and will be recorded as follows (in thousands):
 
 Total2022202320242025
Time-based restricted stock$5,225 $1,302 $2,334 $1,396 $193 
Performance-based restricted stock5,658 1,439 2,552 1,458 209 
 $10,883 $2,741 $4,886 $2,854 $402